Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 13.25
-0.25 (-1.85%)
Jan 22, 2026, 4:03 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 140.1 million as of January 22, 2026. Its market cap has increased by 39.88% in one year.
Market Cap
140.10M
Enterprise Value
139.47M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.25
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 140.10M, an increase of 4,370.28%. That is a compound annual growth rate of 25.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 140.10M | 36.36% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.93B |
| GSK plc | 72.88B |
| Haleon | 32.41B |
| Smith & Nephew | 10.50B |
| Convatec Group | 4.61B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.05B |
| Genus | 1.90B |